Author

U. Bilitewski

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 3

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 3 Research Focus:drug response / drug discovery· 2 Organism:bacteria (other)· 1 Organism:E. coli· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Research Focus:protein folding & dynamics· 1 Assay:proteomics· 1

Frequent Co-Authors

A. Matthaei· 1 shared A. P. Gunesch· 1 shared B. Wiegmann· 1 shared C. E. Torres-Vargas· 1 shared D. Kuehl· 1 shared E. Bohn· 1 shared F. Zapatero· 1 shared G. Brogden· 1 shared

Activity by Year

2019-2021 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 29 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperMicrobiology

A. Matthaei

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Repurposing screen highlights broad-spectrum coronavirus antivirals and their host targets

S. Haid, A. Matthaei, M. Winkler, S. M. Sake, A. P. Gunesch, J. Rueckert, G. Vieyres, D. Kuehl, T.-T. Nguyen, L. Lasswitz, F. Zapatero, G. Brogden, G. Gerold, B. Wiegmann, U. Bilitewski, , T. Pietschmann

The paper screens a drug library to identify broad-spectrum coronavirus antivirals and their host targets, finding compounds that inhibit both alpha- and beta-coronaviruses.

bioRxiv · Jul 14, 2021 · PreprintMicrobiology

Identification of translocation inhibitors targeting the type III secretion system of enteropathogenic E. coli

S. Mühlen, V. Zapolskii, U. Bilitewski, P. Dersch

This study identifies three compounds that inhibit T3SS-mediated effector translocation in EPEC without affecting bacterial viability or T3SS components.

bioRxiv · May 11, 2021Microbiology

A NanoLuc luciferase-based assay enabling the real-time analysis of protein secretion and injection by bacterial type III secretion systems

S. Westerhausen, M. Nowak, C. E. Torres-Vargas, U. Bilitewski, E. Bohn, I. Grin, S. Wagner

This paper develops a NanoLuc luciferase-based assay to quantitatively monitor bacterial type III secretion and injection of effector proteins into host cells.

bioRxiv · Aug 25, 2019Microbiology